Navigation Links
BioInformatics, LLC New Report - New Media Marketing Channels: Creating Effective Online Life Science Promotional Videos
Date:9/10/2009

ARLINGTON, Va., Sept. 10 /PRNewswire/ -- BioInformatics, LLC (http://www.gene2drug.com), the premier research and advisory firm serving the life science market, announces the pending release of its newest report, New Media Marketing Channels: Creating Effective Online Life Science Promotional Videos. In this study, nearly 1,300 scientists were surveyed for their opinions on marketing videos produced by life science suppliers to find out how videos are discovered, used and shared, and to understand impact on brand awareness and purchasing behavior.

The report is scheduled to release September 20, and is available at pre-release pricing until September 30, 2009.

Life science companies are investing large dollar amounts in creating videos that entertain, inform and call the scientific consumer to action. 65% of scientists believe that life science suppliers should circulate videos to promote a brand or a product, but suppliers need to understand what components of a marketing video will inspire a scientists do more than watch. New Media Marketing Channels: Creating Effective Online Life Science Promotional Videos asks questions that enable the life science supplier to measure the results of a marketing video campaign. This report reveals how scientists learn about online videos and how frequently they watch. It assesses likelihood of forwarding videos, preferences for length and content, and correlates viewing with recommending/purchasing behavior. To provide specific understanding of what makes a video effective -- and memorable, 16 life science videos, produced by the following companies, were rated in 13 areas by the respondents:

Affymetrix (NasdaqGS: AFFX)

Agilent Technologies (NYSE: '/>"/>

SOURCE BioInformatics, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. BioInformatics, LLC New Report - Exploring the Epigenetics Market: Opportunities for Product Placement and Innovations
2. BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products
3. BioInformatics, LLC, A Recognized Sponsor of First Annual Consumer Genetics Show in Boston, June 9-11, 2009
4. Patient Safety Organization of Florida Teams With ECRI Institute PSO for Patient Safety Reporting and Analysis
5. Reportlinker Adds World Anti-Obesity Drugs Market Report
6. Reportlinker Adds World Bone Grafts Market Report
7. Reportlinker Adds North America Air Purification Equipment Market Report
8. BioCrossroads Report Defines Strategic Vision for Global Orthopedics Capital
9. Reportlinker Adds World Cardiac Biomarkers Market Report
10. Reportlinker Adds World Botulinum Toxin Market Report
11. Reportlinker Adds US Cosmetic Surgery Procedures And Products Market Report

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ncer who were treated with cisplatin-based chemoth...ological side effects and Raynaud-like phenomena, ...ccording to a new study published online November ...e . , Marianne Brydy, M.D., of the Department of...n, Norway, and colleagues conducted a cross-sectio...
(Date:11/25/2009)...rt to draw definite conclusions, experts say, , ...In diabetic patients with blocked coronary arterie...t one year whether patients undergo bypass surgery... report. , Bypass surgery has been the standard...ery disease. However, less invasive approaches suc...
(Date:11/25/2009)...l symptoms, study finds , , WEDNESDAY, ...cts are among the potential problems faced by long...ted with cisplatin-based chemotherapy, a new study...n men treated for unilateral testicular cancer bet...rvey conducted from 1998 to 2002. , The researc...
(Date:11/25/2009)...4thStraightYear ,, WASHINGTON,Nov.25/PRNewswi...(LCA-GA)issuedthe 4thAnnualReportCardonLungCancer ...tthislethaldiseaseinthestateofGeorgia.LCA-GAisacha...izationdedicatedexclusivelytopatientsupportandadvo..., (Logo: http://www.newscom.com/cgi-bin/prnh/20081...
(Date:11/25/2009)...ill tumor cells, study finds , , WEDNESD...elivered in a fingernail-size implant eliminated m...The method uses polymer disks, 8.5 millimeters in ...gens and implanted under the skin to reprogram the...rsity scientists who developed the implant predict...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2
...he young and fair skinned tan lovers should give s...ce the development of skin cancer, the European Co...ve arm of the European Union said that its scienti...in cancer. European Commission spokesman Greg...
...latant and unwholesome food marketing is on the ri...obesity. It is evident that food marketing impacts...tary pattern and food habits that can last a lifet...food advertisements on dietary choice. They have p...
...olice today, had seized a large quantity of spurio...n for possession of drugs having fake labels of co...p-off, a police team raided a drug store in Leader...whose genuine versions would have been worth Rs 15...
...anofi Pasteur, the world's third-largest pharmaceu...y have reached an initial agreement to conduct joi...used on humans early next year.// According to...ths to 18 years owing to the increased susceptibil...
...he U.S. Food and Drug Administration has approved ...ment for multiple myeloma, which is a type of bloo...rug will now be able to market Revlimid for use in...earlier been treated with chemotherapy. The ...
...he central government Thursday assured the Delhi H...te of Medical Sciences (AIIMS) director P. Venugop...etition. Additional Solicitor General Gopal S...ng upon the AIIMS governing body's recommendation ...
Other Medicine News:Health News:Agreement for Joint Trials of Avian Flu Vac cine on Humans 2Health News:Venugopal will not be Sacked Before Court Verdict: Central Government 2
(Date:11/25/2009)...re/--TheFDAgrantedtraditionalapprovalforINTELENCE&...nscriptaseinhibitor(NNRTI).INTELENCEistheonlyNNRTI...adultswhoareexperiencingvirologicfailurewithHIV-1s...)agents.Thetraditionalapprovalisbasedon48-weekdata...CEiscurrentlymarketedintheU.S.byTibotecTherapeutic...
(Date:11/25/2009)...ire/--RegadoBiosciences,aprivatelyheldcompanyleadi...controlagents,announcedthatDavidMazzo,PhD,CEOandPr...lHealthCareConferenceattheNewYorkPalaceHotelinNewY...EST)onTuesday,December1andwillincludeanoverviewoft...tprogram,theanticoagulantsystem,REG1.Thehealthcare...
(Date:11/25/2009)...re-FirstCall/--Abaxis,Inc.(Nasdaq: ABAX ),amedical...ysissystems,announcedtodaythatClintSeverson,chairm...ualPiperJaffrayHealthCareConferenceonWednesday,Dec...heNewYorkPalaceHotelinNewYorkCity. ,, AboutAba...rtablebloodanalysissystemsforuseinanyveterinaryorh...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Identafi 28TM 29 3000 Picked by Dentistry Today Magazine as One of the Top 100 Products of 2009 50599 1Identafi 28TM 29 3000 Picked by Dentistry Today Magazine as One of the Top 100 Products of 2009 50599 2Jury Convicts Los Angeles Physician Assistant for Stealing Doctors Identity and Defrauding Medicare in 247 7 Million Scheme 50595 1Jury Convicts Los Angeles Physician Assistant for Stealing Doctors Identity and Defrauding Medicare in 247 7 Million Scheme 50595 2Jury Convicts Los Angeles Physician Assistant for Stealing Doctors Identity and Defrauding Medicare in 247 7 Million Scheme 50595 3Jury Convicts Los Angeles Physician Assistant for Stealing Doctors Identity and Defrauding Medicare in 247 7 Million Scheme 50595 4Growth Hormone May Build Muscle in Older Men 50591 1Growth Hormone May Build Muscle in Older Men 50591 2
...arch 11 InteKrin Therapeutics, Inc., a clinical s..., metabolism and obesity, today announced it has c...y of INT131, a novel, non-TZD selective modulator ... diabetes (T2DM). INT131-007 is a 24 week, high d...controlled study of INT131 at four doses in poorly...
...h 10 BioSpecifics Technologies Corp. (Nasdaq: B...t in class collagenase-based products, today annou...l present a corporate overview at the upcoming Cow...on Tuesday, March 17, 2009, at 9:30am ET at the Bo...ebcast of the presentation can be accessed at www...
Other Medicine Technology:InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study 2
Neumann Tying Forceps - Straight
Neumann Tying Forceps - Angled
Shepard Straight Tying Forceps
Shepard Curved Tying Forceps
Medicine Products: